Search for: "Mylan Pharmaceuticals" Results 21 - 40 of 738
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 May 2023, 12:15 pm by Alec Pronk
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
10 May 2023, 12:15 pm by Alec Pronk
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
The CA upheld this in Neurim v Generics UK Limited (t/a Mylan) [2022] EWCA Civ 370. [read post]
23 Jan 2023, 10:40 am by David W.S. Lieberman
In 2022, the top Whistleblower Law Collaborative False Claims Act and SEC matters returned over $300 million to the government in settlements and recoveries. [read post]
10 Nov 2022, 1:25 pm by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
5 Oct 2022, 8:12 pm by Patent Docs
Patent No. 7,326,708 were either anticipated or rendered obvious by the asserted prior art, in Mylan Pharmaceuticals Inc. v. [read post]
3 Oct 2022, 8:27 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 21-1567 [read post]
1 Oct 2022, 2:31 pm by Lawrence B. Ebert
The outcome: Mylan Pharmaceuticals Inc. [read post]
29 Sep 2022, 1:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
29 Sep 2022, 1:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) earlier today upheld a Patent Trial and Appeal Board (PTAB) decision finding that Mylan Pharmaceuticals, Inc. failed to show that certain claims of Merck Sharp & Dohme Corp. [read post]
31 Aug 2022, 11:12 am by Lebowitz & Mzhen
According to the announcement, the drug product titled “Copaxone”, manufactured by Teva Pharmaceuticals is compatible with Autoject 2. [read post]
15 Aug 2022, 3:10 am by Moll Law Group
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]